Are chemokines essential or secondary participants in allergic responses?
OBJECTIVE
This review will provide a concise and critical overview of the rapidly evolving concepts in chemokine biology with a special relevance to allergic responses. The article is intended for clinicians with little or no expertise in chemokine biology.


METHODS
A detailed literature search was performed through MEDLINE (PubMed). Those reports considered important and relevant to the topic were critically reviewed and their conclusions included.


RESULTS
Chemokines are a group of structurally related small proteins with a common biological activity of inducing directional migration (chemotaxis) of various cell types. Chemokines such as eotaxins and MCP-4 play a key role in selective eosinophil recruitment to sites of inflammation in allergies and asthma. Several other chemokine activities relevant to allergic responses are: activation of basophils and eosinophils to release inflammatory mediators, regulation of IgE responses, and Th1/Th2-type cytokine balance. A number of therapeutic strategies aimed at inhibiting chemokine function are being tested in animal models of allergies and asthma.


CONCLUSIONS
Chemokines have been widely viewed as pathogenic mediators of acute and chronic inflammation and tissue damage in allergies and asthma. On the other hand, recent evidence suggests that endogenous production of certain chemokines might be beneficial to the host in preventing allergic response. Met-RANTES, a modified antagonist of RANTES, and eotaxin receptor (CCR3) antagonists, represent promising novel therapeutic agents potentially useful in atopic disorders. Thus, suppression of chemokines may interrupt the sequence of signals culminating in an allergic response. Whether chemokines are actually essential for an allergic response awaits confirmation with gene knockout animal experiments.
Gangur
V
V
Laboratory of Molecular Immunoregulation, Division of Basic Sciences, National Cancer Institute-Frederick Cancer Research and Development Center, Maryland, USA.
Oppenheim
J J
JJ
D018925:Chemokines / Q000502:physiology*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000503:physiopathology* / Q000517:prevention & control*
D018925:Chemokines